Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01CA057183-03S1
Application #
2097950
Study Section
Special Emphasis Panel (SRC (48))
Project Start
1992-07-20
Project End
1997-06-30
Budget Start
1995-07-01
Budget End
1996-06-30
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost

  Institution

Name
University of California Davis
Department
Urology
Type
Schools of Medicine
DUNS #
094878337
City
Davis
State
CA
Country
United States
Zip Code
95618

  Publications

Gumbiner, L M; Gumerlock, P H; Mack, P C et al. (1999) Overexpression of cyclin D1 is rare in human prostate carcinoma. Prostate 38:40-5
Mack, P C; Chi, S G; Meyers, F J et al. (1998) Increased RB1 abnormalities in human primary prostate cancer following combined androgen blockade. Prostate 34:145-51
Chi, S G; deVere White, R W; Muenzer, J T et al. (1997) Frequent alteration of CDKN2 (p16(INK4A)/MTS1) expression in human primary prostate carcinomas. Clin Cancer Res 3:1889-97
Tricoli, J V; Gumerlock, P H; Yao, J L et al. (1996) Alterations of the retinoblastoma gene in human prostate adenocarcinoma. Genes Chromosomes Cancer 15:108-14
Wertz, I E; Deitch, A D; Gumerlock, P H et al. (1996) Correlation of genetic and immunodetection of TP53 mutations in malignant and benign prostate tissues. Hum Pathol 27:573-80
Chi, S G; deVere White, R W; Meyers, F J et al. (1994) p53 in prostate cancer: frequent expressed transition mutations. J Natl Cancer Inst 86:926-33
Meyers, F J; Chi, S G; Fishman, J R et al. (1993) p53 mutations in benign prostatic hyperplasia. J Natl Cancer Inst 85:1856-8